Home » Eligible Institutions for FID Licenses

Scientists and staff members from pharmaceutical institutes at one of the below 22 universities in Germany, the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and TU Dortmund are eligible users for FID licenses. Additionally, scientists from other institutions can register for an individual account.
Hereafter is the list of the 24 eligible locations in which direct access to the FID licenses should be available via their network:

Location Name of institution
Berlin Freie Universität
Bonn Rheinische Friedrich-Wilhelms-Universität
Braunschweig Technische Universität Carolo Wilhelmina
Dortmund Technische Universität Dortmund
Düsseldorf Heinrich Heine Universität
Erlangen-Nürnberg Friedrich-Alexander-Universität
Frankfurt (Main) Johann-Wolfgang-Goethe-Universität
Freiburg Albert-Ludwigs-Universität
Greifswald Ernst-Moritz-Arndt-Universität
Halle Martin-Luther-Universität Halle-Wittenberg
Hamburg Universität Hamburg
Heidelberg Ruprecht-Karls-Universität
Jena Friedrich-Schiller-Universität
Kiel Christian-Albrechts-Universität
Leipzig Universität Leipzig
Mainz Johannes Gutenberg-Universität
Marburg Philipps-Universität
München Ludwig-Maximilians-Universitiät
Münster Westfälische Wilhelms-Universität
Regensburg Universität Regensburg
Saarbrücken Universität des Saarlandes
Tübingen Eberhard-Karls-Universität
Würzburg Julius-Maximilians-Universität
Saarbrücken Helmholtz-Institut für Pharmazeutische Forschung Saarland


You are not an eligible user, but you are interested in FID licensed journals? Full texts of all articles can be ordered via inter-library loan. Additionally, there is a limited license contingent for scientists from other public institutions. If you have questions, contact us via pubpharm[at]tu-braunschweig.de .

Leave a Reply

Google+ Plus Follow on Twitter Linked Follow

Search Blog


Questions or suggestions – please write to: pubpharm[at]tu-braunschweig.de

Monthly Newsletter

By subscribing to this newsletter you are agreeing to our Data Protection Declaration.